Xenglu 25mg Tablets (28s) are a medication primarily used for the treatment of type 2 diabetes mellitus. The active ingredient in Xenglu is Vildagliptin, a medication in the class of DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors).

Key Features:

• Vildagliptin (25mg): Works by inhibiting the DPP-4 enzyme, which is responsible for breaking down incretin hormones. These hormones help regulate blood sugar levels by enhancing insulin secretion and inhibiting glucagon release.
• Blood Sugar Control: Helps lower blood sugar levels by improving the body’s insulin response to meals and controlling the release of glucose from the liver.
• Oral Formulation: Taken in tablet form, making it convenient for daily use.
• Adjunct to Diet and Exercise: Often prescribed alongside lifestyle changes such as diet and exercise to manage type 2 diabetes effectively.

Benefits:

• Helps control blood sugar levels in adults with type 2 diabetes, reducing the risk of complications associated with uncontrolled blood sugar.
• Can be used alone or in combination with other diabetes medications like metformin.
• Does not cause significant weight gain or low blood sugar (hypoglycemia) when used as directed.

Usage Instructions:

• Typically prescribed as one 25mg tablet once or twice daily, with or without food.
• The dosage may vary depending on the patient’s individual health condition and response to the medication.

Note: Regular monitoring of blood sugar levels is essential while using Xenglu. It should be used under the guidance of a healthcare professional, especially in individuals with kidney or liver conditions.